In the News May 4, 2020

Law360, The Deal, Global Legal Chronicle | Menarini to Buy Stemline Therapeutics

Matt Mamak, Justin Howard, Mark McElreath, Robyn Downing, Natalie Clayton, Maddy Byrd, Mike Stevens, and Brendan Caroll are noted for representing Stemline Therapeutics in its $677 million acquisition by Menarini Group.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.